Cellular therapy (CT) is the transplantation of human cells to repair or replace damaged tissue and/or cells. With new technologies and innovative products, different types of cells may be used as part of a therapy to treat a number of diseases and conditions. Factors such as growing government investments for cell-based research, the rising number of GMP-certified production facilities, and a large number of cell-based therapy clinical trials are propelling the growth of the market.
However, the high cost of cell-based research and low success rate are likely to hamper the market growth during the forecast period. Yet, healthcare industries are making significant use of stem cells for the treatment of patients with cancer, blood disorders, and immune-related disorders.
The outbreak of COVID-19 is expected to have a minimal impact on the cell therapy technologies market. Cell-based research is a vital step during the manufacturing of vaccines, which in turn, can promote the growth of the market. Emerging economies such as India, Brazil, and China are presenting rising opportunities for the use of cell therapy technologies.
Cell Therapy Technologies Market has been segmented based on product, cell type, process, end-user, and region.
On the basis of product, the market has been segmented into consumables, equipment, and systems & software. The consumables segment is to account for the largest share of the market during the forecast timeline. Factors responsible for the growth of this segment are growing investments by key players to develop advanced products and government initiatives for enhancing cell-based research. These factors are contributing to the growth of the cell therapy consumables market.
Cell Type Outlook
On the basis of cell type, the market has been segmented into human cells and animal cells. The human cells segment is expected to grow at the highest rate during the forecast period. The growth of this segment can be mainly attributed to the rising adoption of human cells above animal cells for cell therapeutics research and technological advancements.
On the basis of the process, the market has been segmented into cell processing; cell preservation, distribution and handling; and process monitoring and quality control. The cell processing segment will dominate the market during the forecast period. The cell processing stage involves the highest utilization of cell therapy instruments and media during the processing of culture media. The large share and high growth of this segment can be mainly attributed to this factor.
By end user, the cell therapy technologies market has been segmented into biopharmaceutical & biotechnology companies & CROs and research institutes & cell banks. Biopharmaceutical & biotechnology companies and CROs will dominate the market during the forecast timeline. The high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries are the main factors behind the large share of this segment.
On the basis of region, the cell therapy technologies market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is projected to hold the largest share of the cell therapy technologies market during the forecast period. The large share and dominance of this region can be explained by the growing incidence of CVD, rising disposable income, increasing healthcare expenditure, growing healthcare awareness, and the availability of technologically advanced devices in the region.
- Cell Processing Equipment
- Single-use Equipment
- Other Equipment
- Systems & Software
By Cell Type
- Cell Processing
- Cell Preservation, Distribution, and Handling
- Process Monitoring and Quality Control
By End User
- Biopharmaceutical & Biotechnology Companies and CROs
- Research Institutes and Cell Banks
Regions covered in the report:
North America Cell Therapy Technologies Market:
Asia Pacific Cell Therapy Technologies Market:
- South Korea
- Rest of the Asia Pacific
Europe Cell Therapy Technologies Market:
- The Netherlands
- Rest of the Europe
Middle East & Africa Cell Therapy Technologies Market:
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
South America Cell Therapy Technologies Market:
- Rest of South America
The company analysis section encompasses the competitive scenario of the market, providing a detailed analysis of the market. This helps understand the types of products and solutions offered by the companies in the market across the target application areas. In addition, it highlights the nature of strategies adopted by the market players with regards to a particular product/solution, application, and region to sustain/penetrate the given market.
Major Companies Covered in the report:
- Thermo Fisher Scientific Inc. (US)
- Merck KGaA (Germany)
- MaxCyte (US)
- Danaher Corporation (US)
- Becton, Dickinson and Company (US)
- Lonza Group (Switzerland)
- Sartorius AG (Germany)
- Terumo BCT (US)
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Avantor, Inc. (US)
- Bio-Techne Corporation (US)
- Corning Incorporated (US)
- GE Healthcare (US)
- STEMCELL Technologies, Inc. (Canada)
- Terumo BCT (US)
- In August, 2020, Lonza (Switzerland) has collaborated with IsoPlexis (US) to develop the next generation of precision cell therapy manufacturing.
- In March, 2020, Danaher has acquired the Biopharma business from General Electric Company’s Life Sciences division. The acquisition led to a new business named Cytiva, a standalone operating company within Danaher’s Life Sciences segment.
For more information, contact: [email protected]